2006 Archive

ANN ARBOR, Michigan – EDF Ventures today announced the successful completion of venture funding for Lycera Corporation, a pharmaceutical research and development company created in August 2006. The financing was led by EDF Ventures with the participation of a select group of experienced east coast angel investors. Lycera is developing breakthrough small molecule drugs for the treatment of diseases characterized… Read More

Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase… Read More